Abstract 338, Table 1
| Median (range) | ||||
|---|---|---|---|---|
| Baseline | Post 4 weeks observation | Post 8 weeks treatment | P value (baseline v. post treatment) | |
| CDAI | 175 (153–381) | 170 (154–381) | 54 (28–152) | (P< 0.05) |
| CRP | 33 (9–62) | 33 (9–62) | 8 (4–18) | (P< 0.05) |
| ESR | 36 (8–46) | 24 (10–110) | 12 (7–23) | (P< 0.05) |